ES2259299T3 - Uso de agentes de contraste en la fabricacion de agentes de diagnostico para la visualizacion del lumen intestinal. - Google Patents

Uso de agentes de contraste en la fabricacion de agentes de diagnostico para la visualizacion del lumen intestinal.

Info

Publication number
ES2259299T3
ES2259299T3 ES00993689T ES00993689T ES2259299T3 ES 2259299 T3 ES2259299 T3 ES 2259299T3 ES 00993689 T ES00993689 T ES 00993689T ES 00993689 T ES00993689 T ES 00993689T ES 2259299 T3 ES2259299 T3 ES 2259299T3
Authority
ES
Spain
Prior art keywords
contrast agents
contrast
colon
visualization
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00993689T
Other languages
English (en)
Spanish (es)
Inventor
Michael V. Knopp
Frederik Giesel
Hendrik Von Tengg-Kobligk
Jannis Radeleff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco Imaging SpA
Original Assignee
Bracco Imaging SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI002735 external-priority patent/IT1315273B1/it
Priority claimed from IT2000MI000193A external-priority patent/IT1317816B1/it
Application filed by Bracco Imaging SpA filed Critical Bracco Imaging SpA
Application granted granted Critical
Publication of ES2259299T3 publication Critical patent/ES2259299T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
ES00993689T 1999-12-29 2000-12-21 Uso de agentes de contraste en la fabricacion de agentes de diagnostico para la visualizacion del lumen intestinal. Expired - Lifetime ES2259299T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT1999MI002735 IT1315273B1 (it) 1999-12-29 1999-12-29 Imaging del colon mediante contrastografia.
ITMI99A2735 1999-12-29
IT2000MI000193A IT1317816B1 (it) 2000-02-08 2000-02-08 Imaging del colon mediante contrastografia.
ITMI00A0193 2000-02-08

Publications (1)

Publication Number Publication Date
ES2259299T3 true ES2259299T3 (es) 2006-10-01

Family

ID=26331700

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00993689T Expired - Lifetime ES2259299T3 (es) 1999-12-29 2000-12-21 Uso de agentes de contraste en la fabricacion de agentes de diagnostico para la visualizacion del lumen intestinal.

Country Status (12)

Country Link
US (1) US20030113267A1 (https=)
EP (1) EP1251875B1 (https=)
JP (1) JP4798919B2 (https=)
CN (1) CN1302814C (https=)
AT (1) ATE320272T1 (https=)
AU (1) AU2842901A (https=)
CY (1) CY1105456T1 (https=)
DE (1) DE60026743T2 (https=)
DK (1) DK1251875T3 (https=)
ES (1) ES2259299T3 (https=)
PT (1) PT1251875E (https=)
WO (1) WO2001049326A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7606347B2 (en) * 2004-09-13 2009-10-20 General Electric Company Photon counting x-ray detector with overrange logic control
US7260174B2 (en) 2004-09-13 2007-08-21 General Electric Company Direct conversion energy discriminating CT detector with over-ranging correction
US7599465B2 (en) 2004-11-19 2009-10-06 General Electric Company Detection of thrombi in CT using energy discrimination
US7209536B2 (en) * 2004-11-19 2007-04-24 General Electric Company CT colonography system
US7583779B2 (en) * 2004-11-24 2009-09-01 General Electric Company System and method for acquisition and reconstruction of contrast-enhanced, artifact-reduced CT images
US7382853B2 (en) * 2004-11-24 2008-06-03 General Electric Company Method and system of CT data correction
US7613274B2 (en) * 2007-11-16 2009-11-03 General Electric Company Method and system of energy integrating and photon counting using layered photon counting detector
ES2955349T3 (es) * 2019-09-18 2023-11-30 Bayer Ag Predicción de imágenes MRI mediante un modelo de predicción entrenado por aprendizaje supervisado
JP7587575B2 (ja) * 2019-10-08 2024-11-20 バイエル、アクチエンゲゼルシャフト コントラスト強調のない肝臓のmri画像の生成

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999445A (en) * 1988-06-10 1991-03-12 The Regents Of The University Of California Contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
US5695739A (en) * 1989-06-30 1997-12-09 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
US6039931A (en) * 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5245282A (en) * 1991-06-28 1993-09-14 University Of Virginia Alumni Patents Foundation Three-dimensional magnetic resonance imaging
WO1993003351A1 (en) * 1991-08-09 1993-02-18 The Regents Of The University Of California Amino acid, ester and/or catechol contrast agents for mri
IT1252145B (it) * 1991-11-29 1995-06-05 Bracco Ind Chimica Spa Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
WO1993015093A1 (en) * 1992-01-29 1993-08-05 The Regents Of The University Of California Specific contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
IT1269839B (it) * 1994-05-26 1997-04-15 Bracco Spa Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi
JP4432000B2 (ja) * 1996-12-23 2010-03-17 ブラッコ・リサーチ・ソシエテ・アノニム 患者の消化管の視覚化におけるmri造影の増加用組成物

Also Published As

Publication number Publication date
WO2001049326A1 (en) 2001-07-12
ATE320272T1 (de) 2006-04-15
PT1251875E (pt) 2006-07-31
DK1251875T3 (da) 2006-07-24
EP1251875B1 (en) 2006-03-15
EP1251875A1 (en) 2002-10-30
US20030113267A1 (en) 2003-06-19
JP2003519200A (ja) 2003-06-17
DE60026743D1 (de) 2006-05-11
DE60026743T2 (de) 2006-08-17
CY1105456T1 (el) 2010-04-28
JP4798919B2 (ja) 2011-10-19
AU2842901A (en) 2001-07-16
CN1413119A (zh) 2003-04-23
CN1302814C (zh) 2007-03-07

Similar Documents

Publication Publication Date Title
US4719098A (en) Enteral contrast medium useful for nuclear magnetic resonance imaging and its preparation
US8343462B2 (en) Formulations for use in medical and diagnostic procedures
JP4874802B2 (ja) 医療および診断処置に用いられる造影剤ならびにその使用方法
ES2259299T3 (es) Uso de agentes de contraste en la fabricacion de agentes de diagnostico para la visualizacion del lumen intestinal.
Babaei et al. Synthesis of manganese-incorporated polycaplactone-poly (glyceryl methacrylate) theranostic smart hybrid polymersomes for efficient colon adenocarcinoma treatment
JPH04154729A (ja) 磁気共鳴造影剤
JP2005510531A5 (https=)
JP2003519200A5 (https=)
Nicholson et al. HIDA scanning in gall-bladder disease
Karpagam et al. A study to assess the role of date syrup, pineapple juice, and hematinic syrup as magnetic resonance oral contrast agents in improving the image quality of magnetic resonance cholangiopancreatography
Vercher-Conejero et al. Abdominal splenosis: an often underdiagnosed entity
Jacob et al. Magnetic resonance imaging of urea transporter knockout mice shows renal pelvic abnormalities
Gourtsoyiannis et al. Evaluation of the small intestine by MR imaging
US20040175329A1 (en) Method for continuous visualization of a body lumen
EP0614376A1 (en) A method and formulations useful to improve the study of human body cavities
WO2002020005A1 (en) Use of arginine in endoscopy and other medical procedures
Naik et al. Evaluation of bowel by computed tomography enterography: comparing the water, mannitol and iodinated oral contrast
ITMI992735A1 (it) Imaging del colon mediante contrastografia
ITMI20000193A1 (it) Imaging del colon mediante contrastografia
Valverde et al. Radiographic imaging of nonhuman primates
Thomsen et al. CMR 2005: 14.03 Preliminary clinical experience with oral manganese (CMC-001) for liver imaging in daily routine.
Borthne et al. Contrast Media for MRI of the Gastrointestinal Tract
JPH03284629A (ja) Mri用造影剤
Ringe et al. Advances in biliary imaging: CT and MR cholangiography
Endo et al. Successful scintigraphic visualization of metastatic lesions of a hard palate melanoma with N-isopropyl-p-[123 I]-iodoamphetamine.